Martyn is a corporate Of Counsel primarily advising on private M&A transactions.
Martyn is an English law corporate Of Counsel with expertise in advising on cross-border acquisitions, disposals, private equity, joint ventures and group restructurings. He works closely with clients in the pharmaceutical, asset management, financial services, energy and technology sectors.
Background
Martyn was educated at Cambridge University and BPP University College, London. Martyn joined Herbert Smith Freehills in 2011 and qualified in March 2013.
Experience & expertise
Selected matters
- an affiliate of funds advised by Elliott Advisors (UK) Limited on its sale of Gardant S.p.A. to Italian listed doValue S.p.A. for cash and share consideration, and its participation in doValue's rights issue, for a total aggregate value of €460 million
- Coca-Cola HBC on the acquisition of Brown-Forman Finland Oy, owner of the Finlandia vodka brand, from Brown-Forman Corporation’s wholly-owned subsidiary, Brown-Forman Netherlands BV
- Zydus Lifesciences Limited on its acquisition of the UK based LiqMeds Group
- Biotage AB, a Swedish company listed on the NASDAQ Stockholm Stock Exchange, on the UK aspects of its acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider, from Gamma Biosciences
- Inflexion on the sale of Succession Wealth to Aviva for £385m
- Celulosa Arauco y Constitucion S.A. on its intragroup reorganisation and UK governance matters
- Certares Compass on its €300 million equity investment in Avia Solutions Group
- Certares Opportunities LLC and Knighthead Opportunities Capital Management LLC on their US$225 million equity investment in Global Blue Group Holding AG, a leading strategic technology and payments partner
- A Sovereign Wealth Fund on its investment in certain UK assets
- Ixcellerate Limited on its fundraising by, among others, Mubadala
- Ardonagh on the acquisition of the insurance operations of BGC Partners, Inc. for US$500 million
- OneWeb Holdings (the US-based company that builds a constellation of satellites to enable global broadband access) on the investment by Eutelsat into OneWeb
- The Berkeley Group Holdings plc on its return of cash to shareholders, by way of a B share scheme
- Origin Energy, an Australian-listed energy supply business, on its acquisition of a 20% stake in the UK-headquartered energy supplier, Octopus Energy, and on the implementation by Origin Energy of the Kraken energy technology platform developed by Octopus Energy
- WH Smith plc on its class 1 acquisition of Marshall Retail Group (a US retailer)
- Synthomer plc on its acquisition of OMNOVA Solutions Inc., a global manufacturer of emulsion polymers, specialty chemicals, and functional and decorative surfaces
- Strides Pharma Science Limited, an Indian listed pharmaceuticals company, on the AUD 394 million sale of its entire Australian business, including Arrow Pharmaceuticals to Arrotex (a vehicle established for the purpose of combining Arrow Pharmaceuticals with the Australian and New Zealand businesses of Apotex Inc.)
- Sterling Pharma Solutions Limited on its sale to GHO Capital
- Aurobindo on its EUR 74 million acquisition of Apotex's European operations
- Ahren Innovation Capital on its investment into Rockley Photonics, a supplier of silicon photonic chipsets, IP and custom designs for high volume optics applications
- St Ives plc (now Kin and Carta plc) on the disposal of its books business, Clays Ltd and its marketing activation division (comprising SP Group Limited, Service Graphics Limited, Tactical Solutions UK Limited and Flare Limited)
Sectors
